Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 16 recruiting now official registry

Sarcopenia clinical trials

Every US clinical trial registered for Sarcopenia — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

42 US clinical trials · 16 currently recruiting

The research picture

Sarcopenia has 42 registered US clinical trials, 16 of them open to new participants right now — about 38% of the total.

16
recruiting participants now
38%
of trials open to enrollment
1
in Phase 3–4 (later-stage)
3
top sponsor: Tufts University

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING 300 participants

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Wake Forest University Health Sciences

NCT03998202

RECRUITING 250 participants

Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty

University of California, Los Angeles

NCT04717869

RECRUITING NA 250 participants

Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)

Florida Institute for Human and Machine Cognition

NCT06507189

RECRUITING NA 144 participants

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans

VA Office of Research and Development

NCT04691986

RECRUITING 100 participants

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Bettina Mittendorfer

NCT07083557

RECRUITING 100 participants

Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery

University of North Carolina, Chapel Hill

NCT06988176

RECRUITING NA 100 participants

Adverse Outcomes and Mortality in Liver Transplant

Mayo Clinic

NCT05477277

RECRUITING NA 80 participants

Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

The Cleveland Clinic

NCT07059637

RECRUITING 70 participants

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

The Cleveland Clinic

NCT04869813

RECRUITING NA 66 participants

The Foods & Oil to Repair, Correct and Enhance Strength (FORCES) Study

Ohio State University

NCT06361511

RECRUITING NA 60 participants

The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia

Creighton University

NCT06853275

RECRUITING NA 50 participants

Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment

Ohio University

NCT06828926

RECRUITING NA 36 participants

Strength Training and Resveratrol

Texas Tech University

NCT06585865

RECRUITING NA 24 participants

C-Protein in Fatigue and Aging

University of Oregon

NCT05926219

RECRUITING NA 20 participants

Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

University of California, Davis

NCT06722508

RECRUITING NA 12 participants

Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults

University of Missouri-Columbia

NCT06689618

ACTIVE NOT RECRUITING NA 200 participants

Muscle Insulin Resistance in Aging (Mirage)

AdventHealth Translational Research Institute

NCT02230839

ACTIVE NOT RECRUITING 75 participants

Electrical Stimulation of Human Myocytes in Microgravity

AdventHealth Translational Research Institute

NCT03665051

ACTIVE NOT RECRUITING NA 60 participants

Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes

University of Maryland, Baltimore

NCT02509520

ACTIVE NOT RECRUITING Phase 4 20 participants

Muscle Impact of Treating Osteoporosis

Nami Safai Haeri

NCT05666310

COMPLETED NA 200 participants

Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients

The Cleveland Clinic

NCT03636412

COMPLETED NA 150 participants

Efficacy of Nutritional Supplementation on Physical-activity Mediated Changes in Physical Functioning Older Adults at Risk for Mobility Disability (The VIVE2 Study)

Tufts University

NCT01542892

COMPLETED 112 participants

Improving Muscle Assessment in Older Adults - The "Can We Build a Better Mouse Trap?" Study

University of Wisconsin, Madison

NCT02295241

COMPLETED Phase 2 108 participants

HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

National Institute on Aging (NIA)

NCT00183040

COMPLETED 96 participants

Evaluation of the Reproducibility of Jumping Mechanography

University of Wisconsin, Madison

NCT01164670

COMPLETED NA 77 participants

Fish Oil and Muscle Function

Washington University School of Medicine

NCT01308957

COMPLETED NA 70 participants

The Urinary Incontinence Treatment Study

Wake Forest University Health Sciences

NCT03057834

COMPLETED 63 participants

Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle

University of Florida

NCT01644279

COMPLETED NA 56 participants

Culinary Medicine to Enhance Protein Intake on Muscle Quality in Older Adults

Texas Tech University

NCT05593978

COMPLETED NA 46 participants

The Effect of the DASH Diet Containing Meat on Muscle and Metabolic Health in Older Adults

South Dakota State University

NCT04127240

COMPLETED NA 41 participants

Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly

Astavita

NCT03368872

COMPLETED Phase 2 40 participants

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

TNF Pharmaceuticals

NCT05283486

COMPLETED NA 40 participants

IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial

The University of Texas Medical Branch, Galveston

NCT01869348

COMPLETED Phase 2 34 participants

Biological Effects of Weight Loss In Older, Obese Women

University of Florida

NCT01032733

COMPLETED 29 participants

Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults

Tufts University

NCT02811445

COMPLETED NA 24 participants

A Pilot Study of the Impact of Vitamin D3 on Muscle Performance in Elderly Women

Tufts University

NCT00986596

COMPLETED Phase 1 23 participants

The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity

Sara Espinoza

NCT03119610

COMPLETED NA 20 participants

Effects of Multicomponent Training in Older Adults

Geisinger Clinic

NCT06094413

COMPLETED NA 15 participants

The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women

University of California, Davis

NCT05863507

COMPLETED Phase 1 13 participants

Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals

Indiana University

NCT03595774

COMPLETED 12 participants

PET/CT of Skeletal Muscle Amino Acid Kinetics

University of California, San Francis

NCT01698424

COMPLETED Phase 2 11 participants

Trial of Oral Glutamine on Mitochondrial Function in CKD

University of Washington

NCT02838979

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4
Phase 4 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Sarcopenia Trial Landscape

ClinicalTrials.gov lists 42 US studies indexed under Sarcopenia, and 16 of those are currently open to recruitment — roughly 38% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Sarcopenia shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Sarcopenia is led by Tufts University with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 42 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Sarcopenia?

PlainTrial tracks 42 US clinical trials for Sarcopenia, of which 16 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Sarcopenia?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →